United States· US:68083-626_d45de474-a50b-4bb3-a833-3b163803a9fc
Brimonidine Tartrate
A medicinal product containing brimonidine tartrate, registered in United States by Gland Pharma Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BRIMONIDINE TARTRATE
- Manufacturer
- Gland Pharma Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1168083-626-05
- ndc1168083-626-10
- ndc1168083-626-15
- ndc1168083626051 BOTTLE in 1 CARTON (68083-626-05) / 5 mL in 1 BOTTLE
- ndc1168083626101 BOTTLE in 1 CARTON (68083-626-10) / 10 mL in 1 BOTTLE
- ndc1168083626151 BOTTLE in 1 CARTON (68083-626-15) / 15 mL in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brimonidine tartrate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALPHAGANAbbVie s.r.o., Praha
- United KingdomAlphagan 0.2% eye dropsDowelhurst Ltd
- GermanyAlphaganAbbvie Deutschland Gmbh & Co. Kg
- SpainABRADEL 2 MG/ML COLIRIO EN SOLUCIONTiedra Farmaceutica S.L.
- ItalyALPHAGANMEDIFARM S.R.L.
- CanadaALPHAGANABBVIE CORPORATION
- FranceALPHAGAN 0,2 % (2mg/ml), collyre en solutionABBVIE
- PolandAlphaganAbbVie Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Alpha-Vision Sine, Alphagan
- Belgium · Alphagan, Lumobry
- Bulgaria · Brimogen, Бримонидин Абр
- Cyprus · Brimontal, Corneax
- Czechia · Alphagan, Brimonidin Olikla
- Germany · Alphagan, Brimo-Vision
- Denmark · Alphagan, Brimonidintartrat 1a Farma
- Spain · Abradel, Alphagan
- Finland · Alphagan, Lumobry
- France · Alphagan, Brimazed
- United Kingdom (Northern Ireland) · Alphagan, Brimonidine Omnivision
- Greece · Alphagan, Brimofree
- Croatia · Alphagan, Bimanox
- Hungary · Brimogen, Lumobry
- Ireland · Alphagan, Lumobry
- Iceland · Alphagan, Brimonidin Bluefish
- Italy · Alphagan, Brimofree
- Liechtenstein · Mirvaso
- Lithuania · Brimonal, Brimonidine Tartrate Elvim
- Luxembourg · Alphagan, Brimonidin Micro Labs
- Latvia · Briglafre, Brimonal
- Malta · Alphagan, Brimogan
- Netherlands · Alphagan, Brimonidine Stulln
- Norway · Alphagan, Brymont
- Poland · Alphagan, Biprolast
- Portugal · Alphagan, Bglau
- Romania · Brimonal 2 Mg/Ml, Brimonidină Rompharm
- Sweden · Alphagan, Brimonidin Bluefish
- Slovenia · Bimanox, Luvify
- Slovakia · Brimonal, Brimonidin Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aac01295-39aa-40b0-a193-da16c0f289c0 GET /v1/drugs/aac01295-39aa-40b0-a193-da16c0f289c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "1",
"substance": "BRIMONIDINE TARTRATE",
"productndc": "68083-626",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA219219",
"marketing_category": "ANDA"
}See everything about brimonidine tartrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.